Biennial screening of women with dense breast tissue using both mammography and tomosynthesis is cost-effective.
Mammography plus tomosynthesis screening, done biennially for women aged 50 to 74 who have dense breast tissues, is cost effective compared with biennial mammography alone, according to a study published in the journal Radiology.
Researchers from the University of Washington in Seattle; University of Wisconsin in Milwaukee; University of Vermont in Burlington; Dartmouth University in Dartmouth, NH; University of California-Davis, University of California-San Francisco; and Harvard Medical School Harvard Pilgrim Health Care Institute in Boston, MA, evaluated the effectiveness of the combined screening by using an established, discrete-event breast cancer simulation model.
“Screening MRI is the most sensitive breast imaging test, but is also more expensive, requires intravenous contrast injection and is currently reserved for screening women at high risk for breast cancer,” said corresponding author Christoph I. Lee, MD, assistant professor in the Departments of Radiology Health Services, University of Washington, in a release. “Digital breast tomosynthesis, in contrast to MRI, may offer operational and ease-of-use advantages since it is an integrated part of newer generation mammography units.”
The researchers used data and metrics from the National Cancer Institute’s Breast Cancer Surveillance Consortium, Medicare reimbursement rates, and medical literature. Sensitivity analyses were performed to determine the implications of varying key model parameters, including combined screening sensitivity and specificity, transient utility decrement of diagnostic work-up, and additional cost of tomosynthesis.[[{"type":"media","view_mode":"media_crop","fid":"28853","attributes":{"alt":"Christoph I. Lee, MD, corresponding author","class":"media-image media-image-right","id":"media_crop_8379951117708","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"2958","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 233px; width: 166px; border-width: 0px; border-style: solid; margin: 1px; float: right;","title":"Christoph I. Lee, MD, corresponding author","typeof":"foaf:Image"}}]]
The results showed that the incremental cost per quality-adjusted life year (QALY) gained by adding tomosynthesis to digital mammography screening was $53,893. An additional 0.5 deaths were averted and 405 false-positives were avoided per 1,000 women after 12 rounds of screening. Combined screening remained cost-effective (less than $100,000 per QALY gained).
The researchers concluded that if priced appropriately (up to $226 for combined examinations versus $139 for digital mammography alone), biennial combined digital mammography and tomosynthesis for women aged 50 to 74 with dense breast tissue would likely be cost-effective.
“The decrease in false-positive results after adding tomosynthesis is a major contributor to the cost-effectiveness of combined screening,” Lee explained in the release. “Our study suggests that adding tomosynthesis at the time of mammography screening has the potential to decrease the number of unnecessary diagnostic work-ups and invasive procedures that result from false-positive findings.”
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
March 18th 2025While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.
ECR Mammography Study: Pre-Op CEM Detects 34 Percent More Multifocal Masses than Mammography
February 28th 2025In addition to contrast-enhanced mammography (CEM) demonstrating over a 90 percent detection rate for multifocal masses, researchers found that no significant difference between histological measurements and CEM, according to study findings presented at the European Congress of Radiology.
Study: Mammography AI Leads to 29 Percent Increase in Breast Cancer Detection
February 5th 2025Use of the mammography AI software had a nearly equivalent false positive rate as unassisted radiologist interpretation and resulted in a 44 percent reduction in screen reading workload, according to findings from a randomized controlled trial involving over 105,000 women.